Karyopharm Therapeutics Overview
Karyopharm Therapeutics Target Price
Analysts' 12-month price predictions for KPTI.
Get informed when a big investor buys or sells
+ FollowShare Price
$9
Average Target Price
$19.00
111.1% upside
111.1% upside3 analysts in the last 4 months
High: $28 | Low: $13
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-06 | H.C. Wainwright | $13 | 44.4% upside |  |
| 2026-04-27 | Piper Sandler | $16 | 77.8% upside | |
| 2026-03-09 | UBS | $28 | 211.1% upside | |
| 2025-12-17 | Piper Sandler | $12 | 33.3% upside | |
| 2025-12-17 | Goldman Sachs | $12 | 33.3% upside | |
| 2025-11-04 | RBC CapitalBrian Abrahams | $19 | 111.1% upside | |
| 2025-10-13 | H.C. WainwrightRobert Burns | $15 | 66.7% upside | |
| 2025-10-09 | Robert W. Baird | $21 | 133.3% upside | |
| 2025-10-08 | Leerink Partners | $6 |  33.3% downside | |
| 2024-06-10 | RBC CapitalBrian Abrahams | $3 | 66.7% downside | |
| 2023-01-10 | Leerink Partners | $5 | 44.4% downside | |
| 2022-08-23 | Robert W. BairdCollen Kusy | $14 | 55.6% upside | |
| 2022-03-10 | RBC CapitalBrian Abrahams | $8 | 11.1% downside | |